22 completed, 4 unknown, 2 not yet recruiting, 2 recruiting. 15 Not applicable, 4 Phase 2, 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 15 | Completed 8, Unknown 3, Not yet recruiting 2, Recruiting 1, Terminated 1 |
| Phase 2 | 4 | Completed 3, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Urinary Bladder, Underactive: new trials by email Literature Review of Urinary Bladder, Underactive trials Research Report on Urinary Bladder, Underactive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Proof-Of-Concept (POC) Study of SFG-02 Transdermal Formulation in Participants With Underactive Bladder (UAB) SFG-02, Placebo - Participants With Underactive Bladder (UAB) | Phase 2 | Recruiting | Juro Sciences Inc. | 70 | 2026-08-22 | 2026-10-30 |
| The Effect of Detrusor Underactivity in Determining Outcomes After Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia transurethral resection of Prostate - Detrusor Underactivity, Transurethral Resection of the Prostate (TURP) | Not applicable | Not yet recruiting | Ain Shams University | 90 | 2026-05-01 | 2026-05-20 |
| Akyva First In Human Direct Bladder Wall Stimulation - Underactive Bladder | Not applicable | Recruiting | Iota Biosciences, Inc | 15 | 2025-09-24 | 2026-09-14 |
| EEP in Patients With Urodynamically Proven DU/DA Endoscopic enucleation of the prostate - Lower Urinary Tract Symptoms, Lower Urinary Tract Obstructive Syndrome | Not applicable | Not yet recruiting | EEPiDuDa Study Group | 300 | 2024-09-01 | 2024-06-11 |
| The Efficacy of Pyridostigmine Therapy After Transurethral Resection of Prostate in Cases with Underactive Urinary Bladder. Pyridostigmine oral tablet, Placebo - Underactive Bladder, TURP(transurethral Resection of Prostate) | Phase 4 | Completed | Menoufia University | 66 | 2024-04-01 | 2025-03-26 |
| Can Acupoint Low Intensity Shockwave Therapy Improve Bladder Voiding Efficiency Low Intensity Shockwave Therapy (LiSWT), Tamsulosin - Detrusor Underactivity | Not applicable | Unknown | Taichung Armed Forces General Hospital | 100 | 2023-08-11 | 2024-03-05 |
| GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology Intermittent self-catheterisation - Bladder Outlet Obstruction, Multiple Sclerosis | Completed | ConvaTec Inc. | 72 | 2023-02-02 | 2024-04-30 | |
| Codesign of an Optical Device to Measure Urine Flow and Volume Focus Group - Urinary Incontinence, Urinary Retention | Unknown | Teesside University | 45 | 2022-11-01 | 2022-10-12 | |
| Amplifying Sensation in Underactive Bladder Neurometer Neurotron CPT, Cystometry, Pressure-flow study - Urinary Bladder, Underactive | Not applicable | Completed | Duke University | 20 | 2021-09-01 | 2025-07-16 |
| First-in-man Safety and Efficacy Trial of a Novel Non-invasive Bladder Emptying Device: The NIBED Study Non-invasive bladder emptying device - Urinary Retention | Not applicable | Terminated | Insel Gruppe AG, University Hospital Bern | 10 | 2021-07-26 | 2022-06-13 |
| SNM vs. HBOT for Refractory IC/BPS Sacral Neuromodulation (SNM), Hyperbaric Oxygen Therapy (HBOT) - Interstitial Cystitis/Bladder Pain Syndrome, Underactive Bladder | Not applicable | Completed | Shiyan City Renmin Hospital | 88 | 2021-02-01 | 2025-07-29 |
| Previously Implanted Pudendal Nerve Stimulation Medtronic Interstim II Model 3058 Neurostimulator - Urinary Retention, Underactive Bladder | Not applicable | Completed | University of Michigan | 5 | 2021-01-19 | 2024-06-03 |
| Pudendal Nerve Mapping Towards Improved Neuromodulation for Urinary Retention Participants received a Neurostimulator, which was used to map the pudendal nerve - Urinary Retention, Underactive Bladder | Not applicable | Completed | University of Michigan | 22 | 2020-09-14 | 2024-08-20 |
| Detrusor Underactivity: Presentation and Urodynamic Characteristics Symptom questionnaire, Urodynamics - Detrusor Underactivity | Completed | Mutah University | 206 | 2020-01-20 | 2020-04-07 | |
| Superficial Peroneal Nerve Neuromodulation for Non-Obstructive Urinary Retention superficial peroneal nerve stimulation - Urinary Retention, Urinary Bladder, Underactive | Not applicable | Completed | Christopher J Chermansky, MD | 2 | 2019-12-20 | 2025-03-20 |
| Extracoporeal Shock Wave Therapy (ESWT) for the Treatment of Detrusor Underactivity/ Underactive Bladder (DU/UAB) Extracoporeal shock wave therapy, Placebo - Detrusor, Underactive, Detrusor Underactivity | Not applicable | Completed | Chang Gung Memorial Hospital | 11 | 2019-10-15 | 2022-10-05 |
| The Treatment Efficacy of Prolotherapy in Bladder Voiding Dysfunction prolotherapy - Overactive Bladder, Underactive Bladder | Not applicable | Unknown | Taichung Armed Forces General Hospital | 80 | 2019-05-01 | 2023-08-29 |
| Delta Q Value to Discriminate Detrusor Underactivity From Bladder Outlet Obstruction Uroflowmetry - Urinary Obstruction, Detrusor Underactivity | Phase 2 / Phase 3 | Completed | Ain Shams University | 238 | 2019-01-01 | 2022-05-03 |
| Contribution of Urethral Sensory Feedback in Voiding Efficiency lidocaine gel, Plain aqueous gel - Urethral Anesthesia | Not applicable | Completed | Duke University | 18 | 2018-11-26 | 2019-11-14 |
| A Study of ASP8302 in Participants With Underactive Bladder ASP8302, Placebo - Underactive Bladder | Phase 2 | Completed | Astellas Pharma Europe B.V. | 135 | 2018-11-20 | 2024-11-21 |
Showing 20 of 31. Sign in to see all of them.
Urinary Bladder, Overactive (6) · Urinary Retention (6) · Urinary Bladder Neck Obstruction (5) · Lower Urinary Tract Symptoms (4) · Prostatic Hyperplasia (3) · Urinary Bladder, Neurogenic (3) · Urinary Incontinence (3) · Cystocele (2) · Cauda Equina Syndrome (1) · Cystitis, Interstitial (1) · Multiple Sclerosis (1) · Pain (1) · Parkinson Disease (1) · Spinal Cord Injuries (1)
Female Urogenital Diseases (31) · Female Urogenital Diseases and Pregnancy Complications (31) · Male Urogenital Diseases (31) · Pathological Conditions, Signs and Symptoms (31) · Signs and Symptoms (31) · Urinary Bladder Diseases (31) · Urogenital Diseases (31) · Urologic Diseases (31) · Urological Manifestations (31) · Lower Urinary Tract Symptoms (27) · Urination Disorders (7) · Urethral Diseases (5) · Urethral Obstruction (5) · Genital Diseases (3) · Genital Diseases, Male (3)
Urodynamics (2) · Focus Groups (1) · Gels (1) · Hyperbaric Oxygenation (1) · Lidocaine (1) · Prolotherapy (1) · Pyridostigmine Bromide (1) · Solifenacin Succinate (1) · Tamsulosin (1) · Transurethral Resection of Prostate (1) · tac-302 (1)
National Taiwan University Hospital (4) · Duke University (3) · Ain Shams University (2) · Taichung Armed Forces General Hospital (2) · University of Michigan (2) · Astellas Pharma Europe B.V. (1) · Chang Gung Memorial Hospital (1) · Christopher J Chermansky, MD (1) · ConvaTec Inc. (1) · EEPiDuDa Study Group (1) · Insel Gruppe AG, University Hospital Bern (1) · Iota Biosciences, Inc (1) · Jason Gilleran (1) · Juro Sciences Inc. (1) · Menoufia University (1)
United States (9) · Taiwan (6) · Japan (3) · United Kingdom (3) · Egypt (2) · Australia (1) · China (1) · France (1) · Germany (1) · Italy (1) · Jordan (1) · Netherlands (1) · Poland (1) · Slovakia (1) · South Korea (1)
Ho-Hsiung Lin, PhD (3) · Priyanka Gupta, M.D. (2) · Tim Bruns, Ph.D. (2) · Athene Lane, PhD (1) · Bernhard Kiss (1) · Carmela Cusumano, MS, CCRP, CMDA (1) · Chris Harding (1) · Christopher Chermansky, MD (1) · Cindy L Amundsen, MD (1) · Jason Gilleran, MD (1) · Jing-Dung Shen, MD (1) · Jing-dung Shen (1) · Kwanjin Park, MD, PhD (1) · Marcus Drake, DM, MA, FRCS(Urol) (1)
PMID 28754926, PMID 15540753, PMID 16804634, PMID 19937315, PMID 22415792, PMID 23722818, PMID 11874310, PMID 15920223, PMID 15989095, PMID 16223407, PMID 18490916, PMID 19913821, PMID 19941278, PMID 20171677, PMID 21256210, PMID 25316994, PMID 25623739, PMID 26337427, PMID 26555692, PMID 26573101, PMID 28778254, PMID 29270721, PMID 29300256, PMID 29465566, PMID 29628732, PMID 30231245, PMID 30311686, PMID 30592331, PMID 31047905, PMID 31465791, PMID 35419807, PMID 36205739, PMID 39927446, PMID 7832306
OT2OD028191 (2), 2017 (1)